Overexpression of PGC-1α Increases Fatty Acid Oxidative Capacity of Human Skeletal Muscle Cells by Nikolić, Nataša et al.
Hindawi Publishing Corporation
Biochemistry Research International
Volume 2012, Article ID 714074, 12 pages
doi:10.1155/2012/714074
Research Article
Overexpression of PGC-1α Increases Fatty Acid Oxidative
Capacityof HumanSkeletal MuscleCells
Nataˇ saNikoli´ c,1 Magdalena Rhedin,2 ArildC.Rustan,1 Len Storlien,3
G. Hege Thoresen,1 andMaria Str¨ omstedt2
1Department of Pharmaceutical Biosciences, School of Pharmacy, University of Oslo, P.O. Box 1068 Blindern, N-0316 Oslo, Norway
2AstraZeneca Reseach and Development, SE-43185 M¨ olndal, Sweden
3Boden Institute of Obesity, Nutrition and Exercise, University of Sydney, Sydney, NSW 2006, Australia
Correspondence should be addressed to
G. Hege Thoresen, hege.thoresen@farmasi.uio.no
Received 15 April 2011; Accepted 29 June 2011
Academic Editor: Paul Denny
Copyright © 2012 Nataˇ sa Nikoli´ c et al. This isan open access article distributed under theCreative CommonsAttributionLicense,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
We investigated the eﬀects of PGC-1α (peroxisome proliferator-activated receptor γ coactivator-1α) overexpression on the
oxidative capacity of human skeletal muscle cells ex vivo.P G C - 1 α overexpression increased the oxidation rate of palmitic acid
and mRNA expression of genes regulating lipid metabolism, mitochondrial biogenesis, and function in human myotubes. Basal
andinsulin-stimulateddeoxyglucoseuptakeweredecreased,possiblyduetoupregulationofPDK4mRNA.Expressionoffastﬁber-
type gene marker (MHCIIa) was decreased. Compared to skeletal muscle in vivo,P G C - 1 α overexpression increased expression of
several genes, which were downregulated during the process of cell isolation and culturing. In conclusion, PGC-1α overexpression
increased oxidative capacity of cultured myotubes by improving lipid metabolism, increasing expression of genes involved in
regulation of mitochondrial function and biogenesis, and decreasing expression of MHCIIa. These results suggest that therapies
aimed at increasing PGC-1α expression may have utility in treatment of obesity and obesity-related diseases.
1.Introduction
The genesis of obesity is multifactorial. However, there is
evidence that reduced energy expenditure and in particular
reduced capacity to utilise fat for metabolic fuel are impor-
tantfactors,particularlyintheweightreducedstate[1]PGC-
1α(peroxisome proliferator-activated receptor γ coactivator-
1α) is a transcriptional coactivator initially isolated from
brown adipose tissue [2], but now known to be abundant
in many metabolically active tissues, such as skeletal muscle,
liver, heart, and brain, where PGC-1α plays a major role
in transduction of nutritional and physiological stimuli to
transcriptional metabolic and contractile responses [2, 3].
Among many transcription factors coactivated by
PGC-1α are nuclear respiratory factors (NRF1/2) [4],
myocyte enhancer factor-2 (MEF2) [4], and several mem-
bers of nuclear hormone receptors, including peroxisome
proliferator-activated receptor (PPAR) subtypes—a family
of lipid activated nuclear hormone receptors that play a
key role in mediating adaptive regulation of muscle fatty
acid oxidation [5]. The most common function of PGC-
1α across tissues is regulation of mitochondrial physiology,
but in addition, this family of coactivators controls separate,
tissue-speciﬁc biological programs. In liver, expression of
PGC-1α is strongly induced by fasting and stimulates hepatic
gluconeogenesis and ketogenesis [6, 7]; in heart, it is a
powerful stimulant of mitochondrial gene expression and
biogenesis [8], while PGC-1α deﬁciency in brain has been
shown to lead to behavioral abnormalities associated with
axonal degeneration [9].
In skeletal muscle, PGC-1α is powerfully induced in
conditions of increased physical activity [10–15], when ATP
demand is high and induction of mitochondrial oxidative
function becomes essential in order to adapt and maintain
whole body energy balance. Enhancement of mitochondrial
function and biogenesis occur through PGC-1α coactivation
of nuclear respiratory factor (NRF) [16], and regulation
of genes involved in oxidative phosphorylation is medi-
ated through interactions with estrogen-related receptor α
(ERRα)[ 17]. In addition, adaptation to increased contractile2 Biochemistry Research International
activity involves conversion from type II (fast twitch) to
type I (slow twitch) ﬁbers [18], a process also shown to be
driven by PGC-1α in transgenic animals [16], while muscle-
speciﬁc knock out of PGC-1α in animals has been shown
t ol e a dt oc o n v e r s i o nf r o mt y p eIt ot y p eI Im u s c l eﬁ b e r s ,
exercise intolerance, decrease in mitochondrial proteins
and myopathy [19]. Also in primary skeletal muscle cells
from rats, overexpression of PGC-1α has been shown to
confer a switch toward a more slow myoﬁber phenotype
[20]. Further, overexpression of PGC-1α improved lipid
utilization, insulin signaling and glucose transport in vivo
animal studies [21, 22], while whole body overexpression
of PGC-1α appears to have opposite eﬀects on hepatic and
muscle insulin sensitivity [23]. In cell cultures of rodent
myotubes (C2C12 and L6), overexpression of PGC-1α has
been shown to increase the level of the insulin-regulated
glucose transporter 4 (GLUT4) mRNA and glucose uptake
[24].
Peroxisome proliferator-activated receptor δ (PPARδ)i s
coactivated by PGC-1α in vivo and in vitro, and has been
linked to increased fatty acid oxidation [25]. In addition,
PPARδ, along with PGC-1α, has been identiﬁed as one of
key players mediating eﬀects of exercise at the cellular level
[16, 26, 27] and suggested as a new target for the treatment
of metabolic syndrome [28].
Cultured myotubes are a useful tool in investigating
metabolic processes at cellular level, but limited in their use-
fulness in that they are characterized by glycolytic properties
[29, 30]. PGC-1α has been referred to as “master regulator”
of the coordination of mitochondrial biogenesis, mainly
because increase in PGC-1α has been shown to activate tran-
scription factors that switch muscle cells towards oxidative
metabolism[31–33].However,signiﬁcantreductionofPGC-
1α levels in muscle cell cultures compared to in vivo muscle
extracts has been reported in chicken [34], and the role of
PGC-1α in metabolic processes in skeletal muscle in vitro has
previously been highlighted using adenoviral overexpression
in cell cultures [24], but data describing metabolic eﬀects of
PGC-1α overexpression in primary human skeletal muscle
cells are limited [35].
The aim of the present work was to study whether
overexpressionofPGC-1αinculturedhumanskeletalmuscle
cells from healthy individuals would increase the oxidative
capacity of the cells, promote ﬁber type conversion, and
increase expression of genes involved in mitochondrial
biogenesis and function. Moreover, we wanted to compare
cultured myotubes to skeletal muscle in vivo. Finally, a
possibleinterplaybetweenPGC-1αoverexpressionandphar-
macological activation of PPARδ on fatty acid oxidation and
expression of key genes in lipid metabolism was studied.
2.MaterialsandMethods
2.1. Materials. DMEM-Glutamax, FCS, Ultroser G,
penicillin-streptomycin-amphotericin B, and trypsin-
EDTA were obtained from Life Technology (Paisley,
UK). Skeletal Muscle Growth Medium Bullet Kit was
obtained from Clonetics (BioWittaker, Verviers, Belgium).
[3H]palmitic acid (2.0GBq/mmol) and 2-deoxy-D-
[3H]glucose (222GBq/mmol) were purchased from Dupont
NEN Life Science Products (Boston, MA, USA). Palmitic
acid, BSA (essentially fatty acid-free), Cytochalasin B,
and extracellular matrix gel were purchased from Sigma
Chemicals (St Louis, MO, USA). Insulin Actrapid was from
Novo Nordisk (Bagsvaerd, Denmark). RNeasy Mini kit and
RNase-free DNase were purchased from Qiagen Sciences
(Oslo, Norway). Primers were purchased from Invitrogen
(Oslo, Norway). High capacity cDNA archive kit, SYBR
Green, TaqMan reverse-transcription reagents kit, TaqMan
Universal PCR Master Mix and micro ﬂuidic cards were
purchased from Applied Biosystems (Warrington, UK).
Protein assay kit was purchased from BioRad (Copenhagen,
Denmark). All other chemicals used were of standard
commercial high purity quality.
2.2. Human Skeletal Muscle Biopsies and Cell Cultures.
Muscle biopsy samples of the musculus obliquus internus
abdominis or vastus lateralis were taken from seven healthy
volunteers, and a cell bank of satellite cells was established.
The biopsies were obtained with informed consent and
approval by the National Committee for Research Ethics
( O s l o ,N o r w a y ) .M u s c l ec e l lc u l t u r e sf r e eo fﬁ b r o b l a s t sw e r e
established by the method of Henry et al. [36]. Brieﬂy,
muscle tissue was dissected in Ham’s F-10 medium at
4◦C and dissociated by three successive treatments with
0.05% trypsin/EDTA, and satellite cells were resuspended
in skeletal muscle cell growth medium 2% FCS, 50U/mL
penicillin, 50μg streptomycin, 1.25μg/mL amphotericin B,
and no added insulin. The cells from each donor were grown
separately on culture wells or ﬂasks coated with extracellular
matrixgel[37].After1-2weeks,at ∼80%conﬂuence,growth
medium was replaced by DMEM with 2% FCS, 50U/mL
penicillin, 50μg/mL streptomycin, 1.25μg/mL amphotericin
B, and 25pM insulin to induce diﬀerentiation of myoblasts
into multinucleated myotubes. The cells were cultured in a
humidiﬁed 5% CO2 atmosphere at 37◦C, and medium was
changed every 2-3 days. All myotube cultures were used for
analysis on day 7 or 8 after the onset of diﬀerentiation.
2.3.TransientRetroviralVectorProduction. Thethreeretrovi-
ral constructs used in this study were pBABE (empty vector),
pBABE-hPGC-1α, and pBABE-zsGreen (positive control for
infection eﬃcacy). 293T/17 cells were seeded 8h prior to
transfection at a density of 4 ∗ 106 cells per 100mm culture
dishes in 15mL of DMEM with 2mM L-glutamine and
10% foetal calf serum (FCS). Transfection was performed
usingProFectionMammalianTransfectionSystem(Promega
Biotech, Sweden). DNA mixture was prepared by diluting
following amounts of plasmids: 16μgg e n o m e ,1 6μg pVPack
and 8μg pME-VSV-G to 438μL distilled water per 100mm
culture dish. Fifteen min prior to transfection, 65.5μLC a C l 2
and 500μL HEPES were added to DNA mixture, and 1mL
of DNA/CaCl2/HEPES was then added to each culture dish.
The cells were allowed to incubate at a humidiﬁed 5% CO2
atmosphere at 37◦C for 24h, when medium was replaced
with 10mL fresh prewarmed DMEM with 10mM sodiumBiochemistry Research International 3
butyrate(per100mmculturedish)andincubatedat5%CO2
atmosphereand37◦Cforanadditional 6h.Themediumwas
then removed, and fresh medium without sodium butyrate
was added, and the cells incubated for another 16h. The
medium was collected and the supernatant ﬁltered through
0.45μm pore ﬁlter and used directly to infect cultured
myoblasts.Thedescribedprotocolwasappliedidenticallyfor
productionofallthreeretroviralconstructs:pBABE,pBABE-
hPGC-1α, and pBABE-zsGreeen.
2.4. Retroviral Infection of Cultured Human Myoblasts. Infec-
tion of cultured myoblasts with 100% viral supernatant in
the presence of 2μg/mL polybrene for 24h gave highest
infection eﬃciency in pilot experiments, and these condi-
tions were chosen for further infections. Cultured myoblasts
were seeded at a density of 8000–14000 (depending on
growth rate) cells/cm2 and infected 1-2 days after seeding
with 2mL (per well in a 6-well plate) 100% retroviral
supernatant containing either pBABE (empty vector), PGC-
1α or pBABE-zsGreen (positive control) in the presence of
2μg/mL polybrene, and incubated for 24h. Thereafter, the
virus-containing medium was replaced by Clonetics SkGM-
BulletKit without insulin. The cells were allowed to reach
∼80% conﬂuence, when medium was replaced by DMEM
with 2% FCS, 50U/mL penicillin, 50μg/mL streptomycin,
1.25μg/mL amphotericin B and 25pM insulin to induce the
diﬀerentiation of myoblasts into multinucleated myotubes.
All experiments on myotube cultures were performed on day
7 or 8 after the onset of diﬀerentiation. Pretreatments with
GW501516 or control (DMSO) were performed 48h prior
to experiments.
2.5. Palmitic Acid Uptake and Oxidation. Myotubes grown
on six-well plates were rinsed with 3mL of PBS and exposed
to [3H]palmitic acid (50μM, 0.5μCi/mL in PBS with 0.5%
fattyacidfreealbumin(BSA)1mL/well),inahumidiﬁed5%
CO2 atmosphere at 37◦C. After 30 or 60min of incubation,
myotubes were placed on ice, and the incubation medium
was transferred to new vials and assayed for labeled acid-
soluble metabolites (ASMs) as previously described [38].
Brieﬂy, incubation medium was precipitated by addition of
150μL of 20% BSA and 80μLo f1 Mp e r c h l o r i ca c i da n d
centrifuged twice (20000g, 5min, 4◦C). The supernatant
was counted for radioactivity by liquid scintillation. No-cell
controls were included. Cells were washed twice with PBS
and lysed in 0.3mL M-PER (Mammalian Protein Extraction
Reagent, Thermo Scientiﬁc). Cell-associated radioactivity
was measured by liquid scintillation. PA uptake was calcu-
lated as the sum of ASM (corrected for no cell control)
in the medium and the cell-associated radioactivity in the
cells. Protein content was determined using the BCA assay
(Pierce).
2.6. Deoxyglucose Transport and Glycogen Synthesis. Myotu-
bes were incubated for 60min in serum-free DMEM with
5.5mM glucose, with or without 10μM cytochalasin B at
37◦C. Deoxyglucose uptake was measured for 15min in the
presence of 10μM unlabeled deoxyglucose and (1μCi/mL)
2-deoxy-D-[3H]glucose in glucose uptake buﬀer (140mM
NaCl, 20mM HEPES, 5mM KCl, 2.5mM MgSO4,1 m M
CaCl2, pH7.4). After incubation, the cells were washed three
times with ice-cold PBS and lysed with 0.3mL M-PER,
and the radioactivity was counted by liquid scintillation.
Noncarrier mediated glucose transport was determined in
the presence of cytochalasin B (10μM) and subtracted
from all values. For measurement of glycogen synthesis,
myotubes were incubated for 2h (37◦C, 5% CO2)i ns e r u m -
free DMEM (±100nM insulin), before adding DMEM with
2μCi/mL D-[U-14C]-glucose in the presence or absence of
100nM insulin for 60min. After 60min, the cells were
washed three times with ice-cold PBS and lysed with 1M
NaOH. Synthesised glycogen was measured as described
[39]. Glycogen synthesis increased linearly within 4h after
insulin stimulation and is presented as nmol·mg cell
protein−1·h−1. The protein content of each sample was
determined accordingto Bradfordusing BSAas the reference
protein.
2.7. RNA Isolation and Analysis of Gene Expression by Quan-
titative Real-Time PCR. Human skeletal muscle biopsies
and myotubes grown in 6-well plates were lysed in 1mL
Trizole reagent (Invitrogen, Oslo, Norway) according to the
supplier’s total RNA isolation protocol. The isolated RNA
was dissolved in RNase-free water, and concentration was
determined by spectrophotometric measurement at 260nm.
All samples were also electrophoresed in 1% agarose gel to
assess integrity of ribosomal bands.
Total RNA from above was treated with DNase (DNA-
free, Ambion) to remove contaminating genomic DNA
before cDNA synthesis. Shortly, 0.1 volume of 10 times
DNase buﬀer, 4–6 units of DNase and water up to 30μL
was added to each sample. Samples were incubated at 37◦C
for 40–45min. DNase inactivation reagent was added to
each sample and removed by centrifugation after 2min
incubation at room temperature.
First strand cDNA synthesis was performed with Super-
Script III First-Strand Synthesis System for RT-PCR (Invit-
rogen, Oslo, Norway) according to supplier protocol. 1μgo f
DNase treated total RNA was used in each synthesis. Priming
of synthesis was accomplished with Oligo(dT)12−18.F o re a c h
synthesis reaction a negative control with no enzyme was
set up. Obtained cDNA was used for relative quantiﬁcation
on Applied Biosystems 7700. Quantitative real-time PCR
was carried out using either TaqMan Universal PCR Master
Mix or SYBR Green PCR Master Mix (both from Applied
BioSystems) in 25μL reactions run in triplicates. Template
for the PCR was ﬁrst strand cDNA from above (amount
equivalent of 5–25ng total RNA). Following forward and
reverse primers and in case of TaqMan Universal PCR
Master Mix, labelled probes, speciﬁc for the diﬀerent
genes, were used at concentrations of 200nM and 400nM,
respectively: CD36: F: GGGAAAGTCACTGCGACATGA,4 Biochemistry Research International
R: GAACTGCAATACCTGGCTTTTCTC, Probe: TACAGA-
TGCAGCCTCATTTCCACCTTTTGT; CPT1b:F :G C G -
CTGGAGGTGGCTTT, R: TCGTGTTCTCGCCTGCAA-
T, Probe: AAACTCCATAGCCATCATCTGCTACAGGGC;
MCAD: F: TACTTGTAGAGCACCAAGCAATATCA, R:
TGCTCTCTGGTAACTCATTCTAGCTAGT, Probe: CAA-
CTTTCATTGCCATTTCAGCCAGCATA; ATGL:F :C G C -
ACCTGTGCCTTAATCTTC, R: GCTGCAAAGTTCTCA-
GGAGTAAAG; HSL: F: CAGAAGATGTCGGAGCCCATA,
R: GGCCAGTGCTGCTTCAGAC; PPARα: F: CTCTCA-
GGAAAGGCCAGTAACAA, R: TGGCCACCAGCGTCT-
TCT, Probe: CACCTTTTGTCATACATGATATGGAGA-
CACTGTGT; PPARγ: F: GTCACGGAACACGTGCAG-
C, R: GCAGGAGCGGGTGAAGACT; PPARδ:F :T G C -
GGCAACTGGTCACC, R: TCTCGGTTTCGGTCTTCT-
TGA; cytochrome C: F: CTGCCAACAACGGAGCATT, R:
CGTGAGCAGGGAGAAGACGTA, Probe: CACCATGCC-
TAGCTCGCACGATGTAG; COXIV: F: CCGCGCTCG-
TTATCATGTG, R: CACCCACTCTTTGTCAAAGCTTT,
Probe: CACTATGTGTACGGCCCCCTCCCG; SOD2:F :
GCTTGTCCAAATCAGGATCCA, R: GCGTGCTCCCAC-
ACATCA; SOD3: F: GGCCTCCATTTGTACCGAAA, R:
CGGGAGTCTCAGGGCTTATG; UCP-2: F: TGAGCTGGT-
GACCTATGACCTCAT, R: AGTGGCAAGGGAGGTCAT-
CTGT, Probe: AAGGATGCCCTCCTGAAAGCCAACCT;
UCP-3:F:CTGCTGGACTATCACCTGCTCA,R:CCACCA-
CTGTGGCACAGAAG, Probe: ACAACTTCCCCTGCC-
ACTTTGTCTCTGC; ERRα: F: GAGAGGAGTATGTTC-
TACTAAAGGCCTT, R: GCCTCGTGCAGGAGCTTCT,
Probe: TCGGCTCATCTTCGATGTGCACAGAGTC, NRF1:
F: CATGCGTTGAGCTACTGACAAAC. R: AGTCCAGCA-
GGGAGAGTTCTGT, mtTFA: F: GCTGAAAGATTCCAA-
GAAGCTAAGG, R: TTCAGAGTCAGACAGATTTTTTTC-
CAG-TT; MHCI: F: CCAGACTGTGTCTGCTCTCTTCAG,
R: CAGGACAAGCTCATGCTCCAT, MHCIIa:F :A A G -
GTCGGCAATGAGTATGTCA,R:CAACCATCCACAGGA-
ACATCTTC.
For all PCR reactions, two types of negative controls
were used. As control for possible ampliﬁcation of remaining
genomic DNA, no enzyme controls from cDNA synthesis
were set up for all primer-probe sets. The other negative
control was with no template included. All signals were
normalizedtohousekeepinggene36B4.Sampleswererunon
ABI Prism 7700 using the default program: ﬁrst, two steps
with 50◦Cf o r2 m i na n d9 5 ◦C for 10min, followed by 40
cycles of 95◦C for 15sec and 60◦C for 1min. When SYBR
GreenPCRMasterMixwasused,PCRproductfromonewell
in each triplicate was loaded on an 2.5% NuSieve Agarose
(BioWhittaker Molecular Applications) gel to conﬁrm one
band in the correct size.
2.8. Immunoblots. Aliquots of 20μg cell protein from total
cell lysates prepared in Laemmli buﬀer were electrophoret-
ically separated on NuPage 4–12% (w/v) Bis-Tris gel (Invit-
rogen), followed by immunoblotting with speciﬁc antibodies
(Anti OxPhos Complex IV, mouse monoclonal 20E8, Cat. A-
21248 from Molecular Probes, Anti Cytochrome C, mouse
monoclonal 7H8. 2C12, Cat. 556433 from BD Pharmingen).
Immunoreactive bands were visualized with ECL Western
blotting detection reagents (Amersham International).
2.9. Statistical Analyses. All statistical analyses were per-
formed using GraphPad Prism 4.0 for Windows (GraphPad
Software Inc., San Diego, CA). Two-tailed paired t-tests were
performed to determine the eﬀects of PGC-1α overexpres-
sion. All values in ﬁgures are presented as mean ± SEM.
Statistical signiﬁcance was set at P<0.05. For gene analysis,
a fold change ≥2o r≤0.5 was considered an increase or a
decrease in expression level, respectively.
3. Results
3.1. Retroviral Overexpression of PGC-1α in Cultured Human
Skeletal Muscle Cells. To determine whether experimental
alterations in PGC-1α expression would aﬀect oxidative
capacity of cultured human skeletal muscle cells, myoblasts
were infected 48h after seeding. Images of myoblasts taken
48h after infection with positive control virus pBABE-
zsGreen are shown in Figure 1. No morphological changes
compared to uninfected control cells were observed in cells
infected with either empty vector or PGC-1α (data not
shown). PGC-1α mRNA expression in cells infected with
PGC-1α increased 150–200-fold compared to cells infected
with empty control vector (Figure 2(a)). In skeletal muscle
biopsies, PGC-1α mRNA expression was about 35-fold
higher than in diﬀerentiated cultured skeletal muscle cells
(Figure 2(b)), thus PGC-1α infection restored the reduction
inPGC-1αmRNAexpressionobservedduring cellculturing.
3.2. PGC-1α Overexpression Increased Palmitic Acid Oxida-
tion. Oxidation of palmitic acid (PA) was measured 7-8
days after the onset of diﬀerentiation. Rate of PA oxidation,
measured as acid soluble metabolites (ASM), was signiﬁ-
cantly increased by 71% (P<0.05) in cells overexpressing
PGC-1α compared to control cells infected with empty
vector (Figure 3(a)). PA oxidation rate in uninfected cells
(4.3 ± 0.7nmol/mg/h) did not diﬀer from the cells infected
with empty control vector (4.0 ± 0.7nmol/mg/h), showing
that the observed increase in fatty acid oxidation rate
(6.8 ± 1.4nmol/mg/h) was due to overexpression of PGC-
1α. Overexpression of PGC-1α did not aﬀect the uptake of
PA compared to cells infected with empty control vector
(Figure 3(b)).
3.3. PGC-1α Overexpression Increased mRNA Expression of
Genes Important for Lipid Metabolism, Mitochondrial Biogen-
esis,andFunction. Toidentifypotentialmechanismsrespon-
sible for the observed eﬀects of PGC-1α overexpression
on PA oxidation, mRNA expressions of selected genes
encodingkeyenzymesregulatingfattyacidtransport,storage
and oxidation pathways and mitochondrial function were
examined (Figure 4).
Among genes involved in lipid metabolism, PGC-1α-
mediated increase in mRNA expression was most distinct
forMCAD(mediumchainacyl-coenzymeAdehydrogenase)
(7.4-fold), but also PPARα was increased 3.2-fold, andBiochemistry Research International 5
(a) (b)
Figure 1: Retrovirus-mediated PGC-1α overexpression in human skeletal muscle cells. Cultured myoblasts were infected 24–48h post
seeding with 100% medium containing positive control virus pBABE-zsGreen in the presence of 2μg/mL polybrene. Cells were incubated in
virus-containing medium for 24h, as described in Section 2. Images were taken 48h post infection. (a) Fluorescence microscope image. (b)
Light microscope image.
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Figure 2: mRNA level of PGC-1α in human skeletal muscle cells infected with retrovirus coding for PGC-1α compared to control cells
infected with empty virus (a), and in muscle biopsies compared to cell cultures (b). mRNA was isolated from muscle biopsies and cultured
myotubes, and mRNA expression was assessed by RT-PCR,as described in Section 2. Values are presented as means ± SEM of 3 experiments,
each representing one donor, with 3 replicates each, normalized to levels of housekeeping gene 36B4.
CPT1b (carnitine palmitoyltransferase 1b) and HSL (hor-
mone sensitive lipase) both 2.7-fold (Figure 4(a)). In com-
parison, mean mRNA expression levels of MCAD, PPARα
and CPT1b in skeletal muscle biopsies were 24-, 22.5- and
191-fold higher than in cultured cells, respectively (Table 1).
Levels of PPARγ,P P A R δ, and fatty acid transport protein
CD36werenotaﬀectedbyPGC-1αoverexpressioninhuman
myotubes (Figure 4(a)).
Overexpression of PGC-1α resulted in a marked increase
in mRNA levels of several important components of
the respiratory chain: cytochrome C (4.5-fold), COX IV
(cytochrome C oxidase IV) (3.6-fold), SOD-2 (superoxide
dismutase-2) (3.6-fold), and SOD-3 (2.9-fold) (Figure 4(b)).
Protein levels of cytochrome C and COXIV were also
increased in cells overexpressing PGC-1α compared to both
cells infected with empty control vector and uninfected cells
(Figure 4(c)). Two important genes involved in regulation of
mitochondrial biogenesis, ERRα (estrogen related receptor
α) and mtTFA (mitochondrial transcription factor A), were
also noticeably increased in PGC-1α cells, by 3.6-fold and
2.2-fold, respectively (Figure 4(b)). Expressions of NRF1
(nuclear respiratory factor 1) and uncoupling proteins UCP-
2 and UCP-3 did not appear to be aﬀected by PGC-
1α overexpression (Figure 5(b)). In biopsies, mean mRNA6 Biochemistry Research International
Empty vector PGC-1α
0
50
100
150
200
∗
P
a
l
m
i
t
i
c
a
c
i
d
o
x
i
d
a
t
i
o
n
,
%
o
f
c
o
n
t
r
o
l
(a)
Empty vector PGC-1α
0
50
100
150
200
P
a
l
m
i
t
i
c
a
c
i
d
u
p
t
a
k
e
,
%
o
f
c
o
n
t
r
o
l
(b)
Figure 3: Eﬀects of PGC-1α overexpression on palmitic acid oxidation (a) and uptake (b) in human myotubes. Myotubes infected with
either empty vector or PGC-1α were incubated with [3H]palmitic acid and assayed for labeled acid soluble metabolites (ASM), as described
in Section 2. (a) Values are presented as means ± SEM (n = 4 experiments, representing 3 diﬀerent donors; with 3 replicates each). (b)
Values are presented as means ± SEM (n = 3 experiments, representing 2 diﬀerent donors; with 3 replicates each). ∗Signiﬁcantly diﬀerent
from empty control vector at P<0.05.
Table 1: Ratio of mean mRNA expression levels in skeletal muscle
biopsies compared to cell cultures. mRNA was isolated from muscle
biopsiesandculturedmyotubes,andexpressionwasassessedbyRT-
PCR,asdescribedinMaterialsandMethods.Valuesarepresentedas
mean ± SEM of 4 experiments, each representing one donor, with
3 replicates each, and normalized to levels of the housekeeping gene
36B4.
Gene Ratio biopsy/cells (+/− SEM)
COXIV 5.0 (0.34)
CPT1b 191.1 (52.7)
Cytochrome C 9.1 (0.38)
ERRα 7.0 (0.5)
MCAD 24.0 (1.7)
PDK4 1203 (300)
PPARα 22.5 (7.3)
PPARδ 1.6 (0.23)
PPARγ 6.5 (2.7)
expression levels of cytochrome C, COX IV, and ERRα
were 9.1-, 5.0-, and 7.0-fold higher than in cultured cells,
respectively (Table 1).
3.4.PPARδ StimulationPotentiatedPGC-1α-InducedPalmitic
Acid Oxidation. We further examined whether eﬀects of
PGC-1α overexpression on fatty acid metabolism in human
myotubes could be potentiated by simultaneously stim-
ulating PPARδ, a known target of PGC-1α coactivation
[25]. We used a highly potent and selective PPARδ ago-
nist, GW501516 [40], which we have previously shown
to increase the rate of oleic acid oxidation in cultured
human skeletal muscle cell [41]. In myotubes overexpressing
PGC-1α, 48h of GW501516 (10nM) treatment seemed to
potentiatePAoxidation(from7.6 ±1.7nmol/mg/hto18.2 ±
5.9nmol/mg/h) compared to myotubes infected with empty
vector (from 4.6 ± 0.1nmol/mg/h to 9.5 ± 2.2nmol/mg/h)
(Figure 5(a)). At the mRNA level, there was an additive
eﬀect of PPARδ activation by GW501516 on PGC-1α-
induced CPT1b expression (Figure 5(b)). Expression of
genes involved in mitochondrial function (cytochrome C,
COXIV, ERRα, UCP-2, and UCP-3) was not aﬀected by
GW501516 treatment (data not shown).
3.5. Overexpression of PGC-1α Decreased Glucose Transport.
TofurtherassessmetaboliceﬀectsofPGC-1αoverexpression,
glucose transport and glycogen synthesis were measured.
In cells overexpressing PGC-1α, deoxyglucose uptake was
decreased compared to cells infected with empty vector
(Figure 6(a)) .T h er a t eo fd e o x y g l u c o s et r a n s p o r tw a s
unchanged in cells infected with empty control vector
compared to uninfected cells (31.7 ± 8.9nmol/mg/min
and 33.3 ± 9.3nmol/mg/min, resp.), while it decreased to
15.6 ± 8.9nmol/mg/min in myotubes overexpressing PGC-
1α. Insulin increased glucose uptake by about 25% both
in control cells and in cells overexpressing PGC-1α (Fig-
ure6(a)).Glycogensynthesiswasalsoinducedbyinsulin,but
neither basal nor insulin-induced glycogen synthesis were
aﬀected by PGC-1α overexpression (Figure 6(b)). The levelBiochemistry Research International 7
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Figure 4: Eﬀects of PGC-1α overexpression on mRNA expression of genes involved in lipid metabolism (a), mitochondrial function and
biogenesis (b) and on protein levels of mitochondrial components cytochrome C and COXIV (c). (a) and (b): mRNA was isolated from
cultured myotubes infected with either empty control or PGC-1α eight days after the onset of the diﬀerentiation. Expression was assessed by
RT-PCR as described in Section 2, and values are presented as means ± SEM of 3 experiments, each representing one donor, with 3 replicates
each, normalized to levels of the housekeeping gene 36B4. A fold change ≥2o r≤0.5 was considered an increase or decrease in expression
level, respectively. (c): Aliquotes from total cell lysates were electrophoretically separated and immunoblotted with speciﬁc antibodies as
described in Section 2. Images represent a single experiment.
of GLUT1 mRNA was unaﬀected by PGC-1α expression,
while GLUT4 mRNA level increased 6-fold (Figure 6(c)).
PDK4 (pyruvate dehydrogenase kinase 4) was also markedly
increased in PGC-1α infected cells (6-fold) (Figure 6(c)).
3.6. PGC-1α Overexpression Reduced Expression of Fiber Type
IIa Gene Marker. To assess the role of PGC-1α on ﬁber-
type gene markers in myotubes, we further investigated
expression of genes speciﬁcally enriched in either type I
(slow) ﬁbers (MHCI) or type IIa (fast) ﬁbers (MHCIIa).
Expression of MHCIIa mRNA was signiﬁcantly decreased in
cells overexpressing PGC-1α (P<0.005) (Figure 7), while
the increase in MHCI mRNA level was not signiﬁcant. Thus,
the MHCI/MHCIIa mRNA ratio was nearly doubled in cells
overexpressing PGC-1α compared to control cells infected
w i t he m p t yv e c t o r( f r o m3 . 4t o5 . 9 ,r e s p . ) .
4. Discussion
The aim of the present study was to determine whether
overexpression of the transcriptional coactivator PGC-1α
would increase oxidative capacity of human skeletal muscle
cells and to compare these cells to skeletal muscle in vivo.
PGC-1α overexpression increased palmitic acid oxidation8 Biochemistry Research International
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Figure 5: Eﬀects of GW501516-treatment in human myotubes overexpressing PGC-1α on palmitic acid oxidation (a) and mRNA levels
of genes involved in lipid and glucose metabolism (b). Myotubes infected with either empty vector or PGC-1α were treated with 10nM
GW501516 or control (0.1% DMSO) for 48h. (a): The cells were incubated with 1mL/well of [3H]palmitic acid and assayed for labeled
acid soluble metabolites (ASM), as described in Section 2. Values are presented as means ± SEM (n = 2 experiments, each representing one
donor, with 3 replicates each). (b): mRNA expression was assessed by RT-PCR as described in Section 2. Values are presented as means ±
SEM(n = 2experiments,eachrepresentingonedonor,with3replicateseach),normalizedtothelevelsofhousekeepinggene36B4incontrol
cells infected with empty vector and treated with DMSO. A fold change ≥2o r≤0.5 was considered an increase or decrease in expression
level, respectively.
and expression of key genes involved in regulation of lipid
metabolism: CPT1b, MCAD, PPARα and HSL, as well as
genes involved in mitochondrial function and biogenesis.
Compared to skeletal muscle in vivo,P G C - 1 α overexpression
increased expression of several genes which were downreg-
ulated during the process of cell isolation and culturing.
Further, our results showed that uptake of glucose in skeletal
muscle cells infected with PGC-1α was decreased, while
m R N Ae x p r e s s i o no fP D K 4w a si n c r e a s e d ,a sw e l la sm R N A
level of GLUT4. Moreover, when PGC-1α was overexpressed,
the ratio of the mRNA level of MHCI (a gene marker of type
I,slowoxidativeﬁbertype)tothatofMHCIIa(agenemarker
ofglycolytic,fast-twitchskeletalmuscleﬁbers)wasincreased.
Human primary myotubes retain some of the metabolic
characteristics of mature skeletal muscles, but are generally
limited, in vitro, by their low oxidative capacity [29, 30].
This is possibly due to downregulation of PGC-1α and
lack of proliferation of mitochondria in the absence of
necessary cell environmental signals. In the present study,
the rate of palmitic acid oxidation was signiﬁcantly increased
when PGC-1α was overexpressed; an eﬀect which cannot
be attributed to increased uptake of palmitic acid from
the medium, as this was unchanged. The increase in the
oxidationrateofpalmiticacidwasaccompaniedbyenhanced
expression of key genes regulating lipid oxidation: CPT1b,
MCAD,andPPARα.ATGLhasbeenshowntobeupregulated
in human skeletal muscle after exercise [42], along with
increased utilization of intramyocellular triacylglycerols,
while protein levels of HSL remain unchanged [42, 43].
In the present work, ATGL and HSL mRNA levels were
increased by 1.6 and 2.4 fold, respectively, when PGC-1α was
overexpressed. Interestingly, an in vivo study has shown that
in human skeletal muscles, ATGL is expressed exclusively in
t y p eI( o x i d a t i v e )ﬁ b e r s[ 44], so upregulation of this gene
could indicate a shift toward more ﬁber type I-like myotubes
when PGC-1α is overexpressed.
PGC-1α has been shown to increase mitochondrial bio-
genesis by several cellular mechanisms [10, 26, 45–47]a n d
to improve lipid oxidation at rest and during submaximal
exercise. We found several components of the respiratory
chain to be increased at the mRNA level, such as cytochrome
C and COXIV, and increase in protein levels of these
two components were also compared by immunoblotting
(Figure 4(c)). mtTFA, a transcription factor downstream
of PGC-1α, critical for mtDNA replication [48], was also
increased, suggesting that biogenesis of mitochondria might
be increased when PGC-1α is overexpressed in cultured
human myotubes. Furthermore, both superoxide dismutases
(SODs) investigated in the present study, the mitochondrial
SOD-2 and the extracellular SOD-3, were upregulated at
mRNAlevelwhenPGC-1αwasoverexpressed.SODscatalyze
the reduction of superoxide anions into hydrogen peroxide
and oxygen, contributing as such to antioxidant defense
of nearly all cells exposed to oxygen, and recent ﬁndings
have shown that SOD-2 overexpression in mice preserves
myoblast mitochondrial mass and function with aging [49].
Recently, PGC-1α and PPARδ have been identiﬁed
as key players in exercise-signaling cascade leading to
mitochondrial biogenesis [16, 27]. In the present work,
we also wanted to investigate whether some of the eﬀectsBiochemistry Research International 9
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Figure 6: Deoxyglucose transport (a), glycogen synthesis (b) and mRNA expression (c) of GLUT1, GLUT4 and PDK4 in human myotubes
infected with either empty vector or PGC-1α. (a): Cultured myotubes infected with either empty vector or PGC-1α were incubated with
1mL/well of serum-free DMEM ± cytochalasin B 10μM for 60min, followed by a 15min exposure to 2-deoxy-D-[3H]glucose (1μCi/mL)
withorwithoutcytochalasinB,andwithorwithoutinsulin,asdescribedinSection2.Valuesarenormalizedtothelevelsofuptakeincontrol
cells infected with empty vector and presented as means ± SEM of 4 experiments, representing 3 diﬀerent donors, with 3 replicates each.
∗Statistically signiﬁcant compared to basal uptake in control cells infected with empty vector (P<0.05) (b): Myotubes infected with either
empty vector or PGC-1α were incubated for 2h in serum-free DMEM (± insulin), and then exposed to D-[14C(U)]glucose ± insulin. After
60min, the cells were washed three times with ice-cold PBS and lysed with 1M NaOH. Synthesised glycogen was measured as described
in Section 2. Values are presented as means ± SEM of 2 experiments, each representing one donor, with 3 replicates each. (c): mRNA
expression of GLUT1, GLUT4 and PDK4. mRNA was isolated from cultured myotubes infected with either empty control vector or PGC-1α
eight days after the onset of diﬀerentiation. Expression was assessed by RT-PCR, and values are presented as means ± SEM of 3 experiments,
each representing one donor, with 3 replicates each, normalized to the levels of housekeeping gene 36B4. A fold change ≥2o r≤0.5 was
considered an increase or decrease in expression level, respectively.10 Biochemistry Research International
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Figure 7: Eﬀects of PGC-1α overexpression on mRNA expression
of ﬁber-type marker genes MHCI and MHCIIa. mRNA was isolated
from cultured myotubes infected with either empty control vector
or PGC-1α, eight days after the onset of diﬀerentiation. Gene
expression was assessed by RT-PCR, and values are presented as
means ± SEM of 3 experiments, each representing one donor, with
3 replicates each, normalized to the levels of housekeeping gene
36B4. ∗Signiﬁcantlydiﬀerentfromcellsinfectedwithemptycontrol
vector at P<0.05.
of PGC-1α overexpression on lipid metabolism and mito-
chondrial function could be potentiated by simultaneously
activating endogenous PPARδ with a selective agonist
GW501516. PPARδ stimulation appeared to enhance PGC-
1α-mediated increase in palmitic acid oxidation and CPT1b
expression. The eﬀect of PPARδ activation on expression of
CPT1b is in agreement with results from in vitro studies
using mouse myotubes [50]. In our study, we could not see
any eﬀect of PPARδ activation on the expression of genes
in mitochondrial function, which is in contrast to what has
beenreportedinthemuscle-speciﬁcVP16-PPARδ transgenic
micebutnot in thetransgenicmiceoverexpressing the native
PPARδ protein [27], and in agreement with results found
in C2C12 cells (skeletal mouse muscle cells) [50], PPARδ
activation did not promote mitochondrial gene expression,
even though it increased fatty acid oxidation, since none
of the genes in electron transport chain were increased by
PPARδ stimulation.
Both PGC-1α and GLUT4 are often deﬁcient in cultured
skeletal muscle cells [24, 34] ,a n di np r i m a r yh u m a n
myotubes, basal glucose uptake is generally mediated by
other glucose transporters, such as GLUT1 and GLUT3
[51, 52]. In the present work, basal glucose uptake was
signiﬁcantly decreased in human myotubes overexpressing
PGC-1α, while GLUT1 mRNA expression was unchanged.
A previous study with adenoviral overexpression of PGC-
1α in C2C12 and L6 cells showed total restoration of
GLUT4 mRNA levels to those observed in vivo,w i t ha3 -
fold increase in insulin-stimulated glucose transport [24].
In our study, overexpression of PGC-1α caused increased
GLUT4 mRNA but did not increase insulin-stimulated
glucose uptake. Inconsistencies between mRNA levels of
GLUTs and functional data have been reported in human
cultured skeletal muscle cells previously [53–55]. However, it
ispossiblethattheobserveddecreaseinglucoseuptakecould
be due to increased mRNA level of PDK4, an inhibitor of
pyruvate dehydrogenase complex, which switches oxidation
towards lipids.
Muscleﬁbretype and oxidative capacityhave been linked
to obesity and insulin resistance with a higher percentage
of type 1 being positively related to insulin action and
inversely with obesity [56, 57]. In addition it has been
shown in studies with transgenic animals that PGC-1α
appears to be an important factor in regulating muscle ﬁber
type determination [16]. In the present study, myotubes
infected with retro virus coding for PGC-1α had in increased
MHCI/MCHIIa ratio based on gene markers for type I
and type IIa ﬁbers respectively. To our knowledge, shift in
ﬁber-type composition has not previously been shown in
cultured human skeletal muscle cells. The fact that there is
a tendency towards increased MHCI/MHCIIa ratio indicates
the possibility of a more complete switching between ﬁber
types at conditions when PGC-1α is overexpressed, also in
cultured skeletal muscle cells.
In summary, in the present study, overexpression of
PGC-1α in cultured human myotubes increased fatty acid
oxidative capacity of the cells and increased expression of
genes involved in regulation of mitochondrial function.
Compared to skeletal muscle in vivo,P G C - 1 α overexpression
increased expression of several genes, which were downreg-
ulated during the process of cell isolation and culturing.
We have also shown that mRNA expression of a fast ﬁber-
type gene marker (MHCIIa) was decreased, suggesting that
PGC-1α may play a role in ﬁber-type regulation in human
myotubes.
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